1. HIV/AIDS-related cardiovascular disease.
- Author
-
Chaves AA, Mihm MJ, Basuray A, Baliga R, Ayers LW, and Bauer JA
- Subjects
- Acquired Immunodeficiency Syndrome complications, Acquired Immunodeficiency Syndrome drug therapy, Animals, Anti-HIV Agents adverse effects, Anti-HIV Agents therapeutic use, Cardiovascular Diseases epidemiology, Cardiovascular Diseases immunology, Cardiovascular Diseases physiopathology, Clinical Trials as Topic, HIV Infections drug therapy, Humans, Substance-Related Disorders complications, United States epidemiology, Cardiovascular Diseases etiology, HIV Infections complications
- Abstract
Recent advances in antiretroviral therapies have enhanced survival of HIV/AIDS patients, but cardiovascular complications have emerged as important issues in this growing patient population. Although the antiviral drug therapies apparently yield cardiac and/or vascular toxicities themselves, several other factors associated with HIV pathogenesis have also been implicated. This brief review provides an overview of the significance and complexities of HIV/ AIDS-related cardiovascular complications and addresses some important mechanistic aspects that may contribute to this important clinical problem.
- Published
- 2004
- Full Text
- View/download PDF